SCHEMBL6436261

SCHEMBL6436261

Cc1ccccc1/C=C\CC(O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
KDM4E B2RXH2 3/20 0.39
APOBEC3A P31941 1/20 0.39
RAB9A P51151 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
AOC3 Q16853 5/20 0.39
RIPK1 Q13546 1/20 0.39
HTT P42858 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TSHR P16473 1/20 0.37
PTGER1 P34995 1/20 0.36
PTGER4 P35408 1/20 0.36
PTGER3 P43115 1/20 0.36
PTGER2 P43116 1/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
GMNN O75496 1/20 0.35
PMP22 Q01453 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6436267 1.00 LMNA (0.44) LMNAKDM4EAPOBEC3ARAB9AAPOBEC3G
SCHEMBL6546667 0.81 TAAR1 (0.41) KDM4EAPOBEC3ARAB9AAPOBEC3GAOC3
SCHEMBL11799416 0.78 CYP2C19 (0.41) LMNAKDM4ERAB9AL3MBTL1ALDH1A1
SCHEMBL11799420 0.78 CYP2C19 (0.41) LMNAKDM4ERAB9AL3MBTL1ALDH1A1
SCHEMBL13458548 0.77 HTR2A (0.53) LMNAKDM4EL3MBTL1AOC3ALDH1A1
SCHEMBL15441563 0.77 HTR2A (0.53) LMNAKDM4EL3MBTL1AOC3ALDH1A1
SCHEMBL7855317 0.74 LMNA (0.54) LMNAKDM4EAPOBEC3ARAB9AAPOBEC3G
SCHEMBL3165882 0.72 ALDH1A1 (0.46) LMNAKDM4EAPOBEC3ARAB9AAPOBEC3G
SCHEMBL4078766 0.72 ALDH1A1 (0.46) LMNAKDM4EAPOBEC3ARAB9AAPOBEC3G
SCHEMBL6435581 0.72 LMNA (0.43) LMNAKDM4EL3MBTL1AOC3RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6867323-B2 Cross-coupling reaction of organosilicon nucleophiles THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2005-03-15 US disclosed
US-20020183516-A1 Cross-coupling reaction of organosilicon nucleophiles UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN 2002-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183516-A1 Cross-coupling reaction of organosilicon nucleophiles TST, HPD, PCNA LMNA 4232/4885KDM4E 2413/4885APOBEC3A 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.